Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05538832 · ClinicalTrials.gov registry record · Early Phase 1
Remote State Representation in Early Psychosis
A Early Phase 1 study, sponsored by University of Minnesota.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 152
- Enrollment target
NCT05538832: Completed Early Phase 1 study, sponsored by University of Minnesota.
NCT05538832 is a Early Phase 1 study that has completed, run by University of Minnesota. The registered enrollment target is 152 participants, above the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (187% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05538832, a Early Phase 1 study, has completed, sponsored by University of Minnesota.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 152 participants
- Enrollment target
Study Summary
The purpose of this study is to examine state representation in individuals aged 18-30 who have been diagnosed with a psychotic illness, as well as young adults who do not have a psychiatric diagnosis. State Representation is our ability to process information about our surroundings. The investigators will complete some observational tests as well as a cognitive training clinical trial.
Primary Outcome
The DPX task variant consists of a series of pattern sequences. One pattern is designated the "A" cue, and another the "X" cue, which requires one response (AX, 60-70% of trials, e.g. respond with the left button), while other sequences require a different response (AY or BX, 12-15% of trials each, or BY, 6-10% of trials, e.g. respond with the right button). Given the strong expectation that X's evokes a valid response, BX trials place demands on the fidelity (stability, memory) of the "B" cue s
Interventions
- DEVICE BrainHQ Computerized Cognitive Training - Visual Perception Training Paradigm
- DEVICE BrainHQ Computerized Cognitive Training - Visual Cognitive Control Training Paradigm
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 152 participants |
| Start Date | 2022-07-27 |
| Est. Completion | 2025-09-30 |
| Phase | Early Phase 1 |
What the finished NCT05538832 record still lists
NCT05538832 is an interventional study that assigns participants to a tested intervention. The registered 152 participants enrollment target is mid-sized for trials with a published cap, above the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (187% higher).
The record links to 0 conditions, and to 2 interventions - of which BrainHQ Computerized Cognitive Training - Visual Perception Training Paradigm is the first listed.
NCT05538832 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05538832 about?
NCT05538832 is a clinical study titled "Remote State Representation in Early Psychosis". The purpose of this study is to examine state representation in individuals aged 18-30 who have been diagnosed with a psychotic illness, as well as young adults who do not have a psychiatric diagnosis. State Representation is our ability to process information about our surroundings. The investigato...
What is the current status of trial NCT05538832?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 152 participants. The study started on 2022-07-27. Estimated completion is 2025-09-30.
What interventions are being tested in trial NCT05538832?
The interventions under investigation include: BrainHQ Computerized Cognitive Training - Visual Perception Training Paradigm (DEVICE), BrainHQ Computerized Cognitive Training - Visual Cognitive Control Training Paradigm (DEVICE).
Who is sponsoring clinical trial NCT05538832?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05538832's enrollment target sits among peer trials
152 98th of 2000 higher than 1,902 of 2,000 other Early Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Early Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03328078 · 152 participants · Phase 1
CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
- NCT04458532 · 152 participants · NA
Exercise Therapy to Improve Cardiovascular Health in Post-Menopausal Women After Treatment for Early Stage Breast Cancer
- NCT04858334 · 152 participants · Phase 2
APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy in Patients With Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 Mutation
- NCT04993859 · 152 participants
Impact of Chemotherapy on Urinary Biomarkers and Non-Invasive Urodynamics in Children
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI